Chronic Inflammation and Cancer Therapy: Molecular Mechanisms and Clinical Advances in Resolution Pharmacology
Year: 2026
Type: article
Abstract: Chronic inflammation is a pivotal pathophysiological process driving carcinogenesis, tumor progression, metastasis, and therapeutic resistance. While the termination of inflammation was historically viewed as a passive dissipation event, recent research has established it as an active biochemical program governed by Specialized Pro-resolving Mediators (SPMs). Based on cutting-edge research from 2022 to 2025 and clinical data, this review provides an in-depth analysis of the failure of lipid class switching, receptor signal transduction networks, the role of resolution-phase macrophages (M-res), and the Sulciner Effect. Furthermore, it highlights Resolution Pharmacology as the emerging fourth pillar of cancer therapy, particularly through nanomedicine and synergistic strategies with immune checkpoint inhibitors.
Source: Biomolecules & Therapeutics
Authors: Boram Kim, Minh Tuan Nguyen, Yongook Lee, Mi Kyung Park, Chang Hoon Lee
Institution: Dongguk University
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7166650118
FWCI:
Cites:
Cited by:
Related to: